These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25762375)

  • 21. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.
    Baltos JA; Paoletta S; Nguyen AT; Gregory KJ; Tosh DK; Christopoulos A; Jacobson KA; May LT
    Mol Pharmacol; 2016 Jul; 90(1):12-22. PubMed ID: 27136943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
    Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
    Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Histamine H
    Micheli L; Durante M; Lucarini E; Sgambellone S; Lucarini L; Di Cesare Mannelli L; Ghelardini C; Masini E
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of Sunitinib-induced cardiotoxicity through the A3 adenosine receptor activation.
    Sandhu H; Cooper S; Hussain A; Mee C; Maddock H
    Eur J Pharmacol; 2017 Nov; 814():95-105. PubMed ID: 28811127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
    Chun J; Lee C; Hwang SW; Im JP; Kim JS
    Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of macrophage inflammatory protein (MIP)-1alpha production and collagen-induced arthritis by adenosine receptor agonists.
    Szabó C; Scott GS; Virág L; Egnaczyk G; Salzman AL; Shanley TP; Haskó G
    Br J Pharmacol; 1998 Sep; 125(2):379-87. PubMed ID: 9786512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism.
    Mlejnek P; Dolezel P
    Acta Physiol (Oxf); 2010 Jun; 199(2):171-9. PubMed ID: 20121715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and functional modulation by agonist MRS5698 and allosteric enhancer LUF6000 at the native A
    Gao ZG; Chen W; Gao RR; Li J; Tosh DK; Hanover JA; Jacobson KA
    Purinergic Signal; 2024 Oct; 20(5):559-570. PubMed ID: 38416332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
    Kim TH; Kim YK; Woo JS
    Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine A3 receptor activation is neuroprotective against retinal neurodegeneration.
    Galvao J; Elvas F; Martins T; Cordeiro MF; Ambrósio AF; Santiago AR
    Exp Eye Res; 2015 Nov; 140():65-74. PubMed ID: 26297614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis.
    Guzman J; Yu JG; Suntres Z; Bozarov A; Cooke H; Javed N; Auer H; Palatini J; Hassanain HH; Cardounel AJ; Javed A; Grants I; Wunderlich JE; Christofi FL
    Inflamm Bowel Dis; 2006 Aug; 12(8):766-89. PubMed ID: 16917233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thio-Cl-IB-MECA, a novel A₃ adenosine receptor agonist, suppresses angiogenesis by regulating PI3K/AKT/mTOR and ERK signaling in endothelial cells.
    Kim GD; Oh J; Jeong LS; Lee SK
    Biochem Biophys Res Commun; 2013 Jul; 437(1):79-86. PubMed ID: 23791876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
    Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P
    J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular dissection of the human A
    Storme J; Cannaert A; Van Craenenbroeck K; Stove CP
    Biochem Pharmacol; 2018 Feb; 148():298-307. PubMed ID: 29309765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
    Janes K; Esposito E; Doyle T; Cuzzocrea S; Tosh DK; Jacobson KA; Salvemini D
    Pain; 2014 Dec; 155(12):2560-2567. PubMed ID: 25242567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells.
    Di Sole F; Cerull R; Babich V; Casavola V; Helmle-Roth C; Burckhardt G
    J Cell Physiol; 2008 Jul; 216(1):221-33. PubMed ID: 18286509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
    Zeng Z; Zhan L; Liao H; Chen L; Lv X
    Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.